Bourgeon Capital Management’s ALX Oncology ALXO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-19,570
| Closed | -$218K | – | 110 |
|
|
2024
Q1 | $218K | Hold |
19,570
| – | – | 0.04% | 105 |
|
|
2023
Q4 | $291K | Hold |
19,570
| – | – | 0.06% | 92 |
|
|
2023
Q3 | $93.9K | Hold |
19,570
| – | – | 0.02% | 122 |
|
|
2023
Q2 | $147K | Hold |
19,570
| – | – | 0.03% | 110 |
|
|
2023
Q1 | $88.5K | Hold |
19,570
| – | – | 0.02% | 121 |
|
|
2022
Q4 | $221K | Hold |
19,570
| – | – | 0.05% | 89 |
|
|
2022
Q3 | $187K | Hold |
19,570
| – | – | 0.05% | 89 |
|
|
2022
Q2 | $158K | Hold |
19,570
| – | – | 0.04% | 99 |
|
|
2022
Q1 | $331K | Hold |
19,570
| – | – | 0.07% | 80 |
|
|
2021
Q4 | $421K | Hold |
19,570
| – | – | 0.09% | 80 |
|
|
2021
Q3 | $1.45M | Hold |
19,570
| – | – | 0.31% | 53 |
|
|
2021
Q2 | $1.07M | Hold |
19,570
| – | – | 0.23% | 65 |
|
|
2021
Q1 | $2.15M | Buy |
+19,570
| New | +$2.15M | 0.48% | 50 |
|